• Something wrong with this record ?

Incidence and survival in oral and pharyngeal cancers in Finland and Sweden through half century

AI. Koskinen, O. Hemminki, A. Försti, K. Hemminki

. 2022 ; 22 (1) : 227. [pub] 20220302

Language English Country Great Britain

Document type Journal Article

Persistent link   https://www.medvik.cz/link/bmc22010800

BACKGROUND: Cancers of the oral cavity and pharynx encompass a heterogeneous group of cancers for which known risk factors include smoking, alcohol consumption and human papilloma virus (HPV) infection but their influence is site-specific with HPV mainly influencing oropharyngeal cancer. Their incidence and survival rates are not well known over extended periods of time. PATIENTS/METHODS: Data were obtained for Finnish (FI) and Swedish (SE) patients from the Nordcan database recently updated through 2019. Age-adjusted incidence trends (FI from 1953, SE from 1960) and relative survival rates for years 1970 through 2019 were calculated. RESULTS: We observed a prominent increase in oral and oropharyngeal cancers in FI and SE men and women but the trend for oral cancer was interrupted for SE men in 1985 and possibly also for FI and SE women in 2015. The trend changes in male and female oral cancer was confirmed in data for Denmark and Norway. Relative survival for these cancers has improved overall but they differed for one cluster of oral, oropharyngeal and nasopharyngeal cancers with 60-70% 5-year survival in the last period and hypopharyngeal cancer with 25% male survival. In all these cancers, survival for old patients was unfavorable. DISCUSSION/CONCLUSION: We hypothesize that reduction in smoking prevalence helped to stop the increase in oral cancer especially in men. As the prevalence of smoking is decreasing, HPV is becoming a dominant risk factor, particularly for the increasing oropharyngeal cancer. Prevention needs to emphasize sexual hygiene and HPV vaccination.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc22010800
003      
CZ-PrNML
005      
20220506130417.0
007      
ta
008      
220425s2022 xxk f 000 0|eng||
009      
AR
024    7_
$a 10.1186/s12885-022-09337-2 $2 doi
035    __
$a (PubMed)35236321
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxk
100    1_
$a Koskinen, Anni I $u Department of Otorhinolaryngology- Head and Neck Surgery, Helsinki University Hospital and University of Helsinki, PO Box 263, 00029, Helsinki, Finland. anni.koskinen@hus.fi
245    10
$a Incidence and survival in oral and pharyngeal cancers in Finland and Sweden through half century / $c AI. Koskinen, O. Hemminki, A. Försti, K. Hemminki
520    9_
$a BACKGROUND: Cancers of the oral cavity and pharynx encompass a heterogeneous group of cancers for which known risk factors include smoking, alcohol consumption and human papilloma virus (HPV) infection but their influence is site-specific with HPV mainly influencing oropharyngeal cancer. Their incidence and survival rates are not well known over extended periods of time. PATIENTS/METHODS: Data were obtained for Finnish (FI) and Swedish (SE) patients from the Nordcan database recently updated through 2019. Age-adjusted incidence trends (FI from 1953, SE from 1960) and relative survival rates for years 1970 through 2019 were calculated. RESULTS: We observed a prominent increase in oral and oropharyngeal cancers in FI and SE men and women but the trend for oral cancer was interrupted for SE men in 1985 and possibly also for FI and SE women in 2015. The trend changes in male and female oral cancer was confirmed in data for Denmark and Norway. Relative survival for these cancers has improved overall but they differed for one cluster of oral, oropharyngeal and nasopharyngeal cancers with 60-70% 5-year survival in the last period and hypopharyngeal cancer with 25% male survival. In all these cancers, survival for old patients was unfavorable. DISCUSSION/CONCLUSION: We hypothesize that reduction in smoking prevalence helped to stop the increase in oral cancer especially in men. As the prevalence of smoking is decreasing, HPV is becoming a dominant risk factor, particularly for the increasing oropharyngeal cancer. Prevention needs to emphasize sexual hygiene and HPV vaccination.
650    _2
$a senioři $7 D000368
650    _2
$a pití alkoholu $x škodlivé účinky $x epidemiologie $7 D000428
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a lidé $7 D006801
650    _2
$a incidence $7 D015994
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a lidé středního věku $7 D008875
650    _2
$a nádory úst $x epidemiologie $x etiologie $7 D009062
650    _2
$a nádory orofaryngu $x epidemiologie $x etiologie $7 D009959
650    _2
$a infekce papilomavirem $x komplikace $x epidemiologie $7 D030361
650    _2
$a nádory hltanu $x epidemiologie $x etiologie $7 D010610
650    _2
$a registrace $7 D012042
650    _2
$a rizikové faktory $7 D012307
650    _2
$a kouření $x škodlivé účinky $x epidemiologie $7 D012907
651    _2
$a Finsko $x epidemiologie $7 D005387
651    _2
$a Švédsko $x epidemiologie $7 D013548
655    _2
$a časopisecké články $7 D016428
700    1_
$a Hemminki, Otto $u Department of Urology, Helsinki University Hospital and University of Helsinki, Helsinki, Finland $u Cancer Gene Therapy Group, Translational Immunology Research Program, University of Helsinki, Helsinki, Finland
700    1_
$a Försti, Asta $u Hopp Children's Cancer Center (KiTZ), Heidelberg, Germany $u Division of Pediatric Neurooncology, German Cancer Research Center (DKFZ), German Cancer Consortium (DKTK), Heidelberg, Germany
700    1_
$a Hemminki, Kari $u Faculty of Medicine and Biomedical Center in Pilsen, Charles University in Prague, 30605, Pilsen, Czech Republic. k.hemminki@dkfz.de $u Division of Cancer Epidemiology, German Cancer Research Centre (DKFZ), 69120, Heidelberg, Germany. k.hemminki@dkfz.de
773    0_
$w MED00008171 $t BMC cancer $x 1471-2407 $g Roč. 22, č. 1 (2022), s. 227
856    41
$u https://pubmed.ncbi.nlm.nih.gov/35236321 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20220425 $b ABA008
991    __
$a 20220506130410 $b ABA008
999    __
$a ok $b bmc $g 1788762 $s 1161998
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2022 $b 22 $c 1 $d 227 $e 20220302 $i 1471-2407 $m BMC cancer $n BMC Cancer $x MED00008171
LZP    __
$a Pubmed-20220425

Find record

Citation metrics

Archiving options